Clinical trial
Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and…
NCT00422734 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00422734 |
|---|---|
| Title | Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life |
| Official title | Tadalafil 5 mg Once a Day Compared to Placebo in Improving Erectile Dysfunction and Sexual Quality of Life |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | ICOS Corporation Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Impotence |
| Intervention type | Drug |
| Interventions | tadalafil, Placebo |
| Enrollment | 342 |
| Start date | Nov 1, 2006 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Jan 17, 2007 |
| Last update posted | Jun 10, 2009 |
| Countries | Austria, France, Germany, Mexico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: